Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7.23M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
9.34M
-
Shares change
-
+284K
-
Total reported value, excl. options
-
$220M
-
Value change
-
+$7.17M
-
Number of buys
-
24
-
Number of sells
-
-16
-
Price
-
$23.60
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q4 2018
47 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q4 2018.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.34M shares
.
Largest 10 shareholders include FMR LLC (2.85M shares), Cormorant Asset Management, LP (1.42M shares), EcoR1 Capital, LLC (1.06M shares), COWEN INC. (833K shares), BB BIOTECH AG (818K shares), Omega Fund Management, LLC (676K shares), FRANKLIN RESOURCES INC (335K shares), FRAZIER MANAGEMENT LLC (250K shares), BlackRock Inc. (246K shares), and VICTORY CAPITAL MANAGEMENT INC (227K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.